Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
System for non-destructive image processing
Registration and network access control
Data processing circuit with arbitration between a plurality of queues
Process and apparatus for producing composite material that includes carbon nanotubes
Spray drying vancomycin
Vacuum cleaner filter adapter ring
Focusing apparatus that effectively sets a focus area of an image when a focusing mode is changed
  Randomly Featured Patents
Method for displaying and formatting messages in web applications using JavaServer Faces
Intervertebral implant with joint parts mounted on roller bodies
Method and structure to control common mode impedance in fan-out regions
Operator presence sensor for operator's seat
Systems and methods for routing emergency communications
Trackable arrow
Flexible magnetic recording media having a polyester-polyurethane binder and chromium dioxide pigment
Method of removing an immiscible lubricant from a refrigeration system and apparatus for same
Alkaline phosphatase
Electroluminescent devices with electrode protection